Assignee
BLACKTHORN THERAPEUTICS INC
US·11 granted patents·2 pending applications·18 citations·filing 2018–2022
Top patents by PatentIndex Score
13 records- 0186US11676732B2Machine learning-based diagnostic classifierBLACKTHORN THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·1 cites·21 claims
- 0282US11103171B2Systems and methods for screening, diagnosing, and stratifying patientsBLACKTHORN THERAPEUTICS INC·Filed 2019·Granted Aug 31, 2021·5 cites·16 claims
- 0381US11139083B2Machine learning-based diagnostic classifierBLACKTHORN THERAPEUTICS INC·Filed 2019·Granted Oct 5, 2021·2 cites·17 claims
- 0480US11715564B2Machine learning-based diagnostic classifierBLACKTHORN THERAPEUTICS INC·Filed 2019·Granted Aug 1, 2023·2 cites·28 claims
- 0578US11857322B2Systems and methods for screening, diagnosing, and stratifying patientsBLACKTHORN THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·1 cites·20 claims
- 0677US11244762B2System and method for identifying transdiagnostic features shared across mental health disordersBLACKTHORN THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·2 cites·9 claims
- 0777US11186577B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Nov 30, 2021·2 cites·11 claims
- 0875US11289187B2Multimodal biomarkers predictive of transdiagnostic symptom severityBLACKTHORN THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·2 cites·8 claims
- 0975US10538530B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·1 cites·104 claims
- 1069US11942224B2System and method for identifying transdiagnostic features shared across mental health disordersBLACKTHORN THERAPEUTICS INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 1167US10950327B2Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subjectBLACKTHORN THERAPEUTICS INC·Filed 2019·Granted Mar 16, 2021·0 cites·7 claims
- 1262US2022172822A1Multimodal biomarkers predictive of transdiagnostic symptom severityBLACKTHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1343US2022139530A1Systems and methods for processing mri dataBLACKTHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →